ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN)

Historical Holders from Q2 2022 to Q4 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
PMN on Nasdaq
Shares outstanding
53,788,752
Price per share
$0.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,993,894
Total reported value
$4,247,586
% of total 13F portfolios
0%
Share change
+1,573,628
Value change
+$501,350
Number of holders
23
Price from insider filings
$0.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Shaf QIC LLC 10% $5,096,658 10,534,639 Shaf QIC LLC 29 Jul 2025
Sclar Jeremy M. 17% $3,804,772 9,511,930 Jeremy M. Sclar 30 Sep 2025
ABG Management Ltd. 11% -4.2% $2,579,922 +$4,958 6,070,405 +0.19% ABG Management Ltd. 22 Oct 2025
GREAT POINT PARTNERS LLC 10% 0% $2,547,215 +$1,125,043 5,972,369 +79% Great Point Partners, LLC 30 Sep 2025
GORDON MICHAEL S 9% $2,363,899 4,886,108 Michael S. Gordon 30 Jun 2025
SPHERA FUNDS MANAGEMENT LTD. 5.5% $1,343,748 3,122,090 Sphera Funds Management Ltd. 30 Sep 2025
ARMISTICE CAPITAL, LLC 5.5% -23% $1,268,632 +$272,829 2,974,518 +27% Armistice Capital, LLC 30 Sep 2025
As of 30 Sep 2025, ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) has 23 institutional shareholders filing 13F forms. They hold 9,993,894 shares. of 53,788,752 outstanding shares (19%) .

Top 25 institutional shareholders own 19% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Ally Bridge Group (NY) LLC 12% 6,233,497 +367% 2.2% $2,649,236
ARMISTICE CAPITAL, LLC 5.5% 2,974,518 +39% 0.04% $1,264,170
SPHERA FUNDS MANAGEMENT LTD. 0.55% 295,187 -84% 0.03% $125,454
CITADEL ADVISORS LLC 0.32% 170,079 +168% 0% $72,284
HRT FINANCIAL LP 0.13% 68,057 0% $28,000
XTX Topco Ltd 0.13% 67,687 0% $28,767
BANK OF MONTREAL /CAN/ 0.06% 30,366 0% 0% $13,057
Fiduciary Trust Co 0.05% 28,583 0% 0% $12,148
IEQ CAPITAL, LLC 0.05% 26,042 0% 0% $11,068
HOWARD FINANCIAL SERVICES, LTD. 0.05% 26,042 0% 0% $11,068
TWO SIGMA INVESTMENTS, LP 0.03% 18,428 0% $7,832
SCOTIA CAPITAL INC. 0.02% 12,122 0% 0% $5,153
COMMONWEALTH EQUITY SERVICES, LLC 0.02% 11,447 0% 0% $5,000
Claret Asset Management Corp 0.02% 11,330 0% 0% $5,000
OSAIC HOLDINGS, INC. 0.02% 9,000 0% $4,770
ROYAL BANK OF CANADA 0.01% 5,487 0% 0% $2,000
UBS Group AG 0% 2,506 0% $1,065
BANK OF AMERICA CORP /DE/ 0% 1,666 0% 0% $708
TD Waterhouse Canada Inc. 0% 940 +607% 0% $422
North Star Investment Management Corp. 0% 500 0% $212
Federation des caisses Desjardins du Quebec 0% 254 0% $106
NATIONAL BANK OF CANADA /FI/ 0% 88 0% 0% $37
JPMORGAN CHASE & CO 0% 68 0% $29
Allostery Investments LP 0% 0 -100% $0
GREAT POINT PARTNERS LLC 0% 0 -100% $0

Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 0 $0 -$11,068 $0.42 0
2025 Q3 9,993,894 $4,247,586 +$501,350 $0.42 23
2025 Q2 8,473,099 $4,101,148 -$540,895 $0.48 19
2025 Q1 9,325,986 $6,489,664 -$305,401 $0.70 17
2024 Q4 9,747,253 $9,238,269 -$516,735 $0.95 18
2024 Q3 10,087,669 $12,611,608 +$8,040,363 $1.25 18
2024 Q2 3,232,221 $4,848,022 -$221,623 $1.50 15
2024 Q1 3,382,907 $6,463,092 +$75,871 $1.91 16
2023 Q4 3,347,909 $3,849,710 +$624,784 $1.15 13
2023 Q3 2,804,768 $5,609,387 +$5,238,947 $1.98 13
2023 Q2 186,447 $723,079 -$4,625 $3.88 12
2023 Q1 187,649 $888,276 -$5,905 $4.73 11
2022 Q4 189,088 $823,550 +$19,204 $4.34 12
2022 Q3 184,593 $1,130,000 +$1,129,000 $6.08 11
2022 Q2 10,000 $1,000 +$1,000 $0.10 1